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Over the past few years, a number of research groups have reported striking progress on the generation of in vitromodels frommouse and
human stem cells that replicate aspects of early embryonic development. Not only do thesemodels reproduce some key cell fate decisions
but, especially in themouse system, they alsomimic the spatiotemporal arrangements of embryonic and extraembryonic tissues that are
required for developmental patterning and implantation in the uterus. If such models could be developed for the early human embryo,
theywould have great potential benefits for understanding early humandevelopment, for biomedical science, and for reducing the use of
animals and human embryos in research. However, guidelines for the ethical conduct of this line of work are at present not well defined.
In this Forum article, we discuss some key aspects of this emerging area of research and provide some recommendations for its ethical
oversight.
The Current State of Research into
Embryo Models from Stem Cells
Beginning with fertilization, the
mammalian conceptus (see Box 1 for
terminology) goes through a charac-
teristic developmental program with
two essential outcomes: (1) the forma-
tion of extraembryonic tissues that
establish connections with the
maternal tissue and fuel the develop-
ment of the embryo proper and (2)
the generation of the three embryonic
germ layers of cells that are the build-
ing blocks of the future organs. These
two processes lay the groundwork for
the developing embryo to form a
fetus.
Although the mammalian
conceptus can develop in vitro up to
the blastocyst stage, in vivo studies
are particularly challenging once im-
plantation in the uterus occurs
(approximately day 7–9 in humans),
due to the small size of the conceptus
and its inaccessibility in the uterine
tissues. Protocols allowing for the
further in vitro development of mouse
blastocysts were developed starting 48
years ago (Hsu, 1971, 1979), but only
recently were these applied to
donated fertility clinic-derived hu-
man blastocysts (Deglincerti et al.,
2016). These in vitro-cultured human
blastocysts reflect some aspects of
early post-implantation stages (Bo
et al., 2019; Deglincerti et al., 2016;
Shahbazi et al., 2016), but their
growth is largely confined to two di-
mensions, they do not yet fullymimic
in vivo development, and they often
show degenerative changes as culture
progresses. Three-dimensional cul-
tures of human blastocysts are now
being developed that better recapitu-
late post-implantation development
in vitro (Xiang et al., 2019). However,
the optimization of culture con-
ditions and the extension of the
development of such cultures risk
contravening the internationally
well-accepted 14-day rule, which
limits research on intact human con-
ceptuses/embryos (see below for defi-
nition of human embryo in law) to
14 consecutive days of development
in vitro from fertilization or the
appearance of the primitive streak,
whichever occurs first. Given these
limitations, the possibility of using
human stem cells to generate in vitro
models of early development repre-
sents an alternative. These models
have important technical advantages,
including accessibility (cell lines are
more widely available than blasto-
cysts and represent a renewable
resource) and the ability to generate
large numbers required for high-
throughput screens and complex
gene editing. A range of different
and complementary models, based
on several types of methodology, has
been devised to mimic specific
stages of mouse and human develop-
ment (Figure 1) (Beccari et al., 2018;
Rivron et al., 2018b; Shao et al.,
2017; Sozen et al., 2018; Warmflash
et al., 2014).
Although none of these models has
yet been demonstrated to be compe-
tent to develop for more than a few
days in vitro, we can envision that
cell culture methodologies could be
refined to a point where the models
capture key features of early mamma-
lian development with sufficient fidel-
ity to minimize differences from the
conceptus itself. When applied to hu-
man cells, such refinements will
greatly enhance the power of the
models but will also elevate ethical
concerns over the conduct of the
research.
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Potential Benefits of This Research
to Human Health
This research could result in substan-
tial scientific and medical advances
with an impact on human health.
These outcomes include
d attaining a fundamental under-
standing of key stages of early
human development through
the availability of versatile and
scalable experimental models;
d achieving abetter understanding
of how stem cells from different
species (e.g., mouse, pig, human)
and different cell lines and states
vary in developmental potential,
to improve their use in research
and therapy;
d improving assisted reproduction
technologies;
d understanding the biology of
germ cells and infertility;
d modeling implantation in three di-
mensions to understand the high
early pregnancy loss and improve
contraception technologies;
d studying the genetics of early
developmental defects using
gene editing technologies;
d revealing how defects in epige-
netic reprogramming during
early development can influence
health throughout the lifespan,
leading to strategies for disease
prevention according to the
developmental origins of health
and disease;
d refining human stem cell differ-
entiation culture methods to
achieve a greater fidelity with
processes occurringduringdevel-
opment (e.g., organogenesis).
The Current State of Regulation of
Research on Human Embryo
Models from Stem Cells
Since this field is relatively new, there
is little explicit regulation of in vitro
human embryo models. However,
research using certain models of early
human development may fall under
existing legislation depending on
how ahuman embryo is defined. Legal
definitions of a human embryo vary
greatly across jurisdictions and are
not necessarily restricted to entities
with the potential to form a full organ-
ism (Box 2). In other jurisdictions,
legislation pertaining to human em-
bryosmay not include an explicit defi-
nition, leading to uncertainty around
how models of human development
would be viewed.
Moreover, this consideration of
developmental or ‘‘organismic’’ poten-
tial (see the International Society for
Stem Cell Research [ISSCR] guidelines,
Box 3) is problematic in the human,
because the definitive experiments to
prove or disprove full human develop-
mental potential are obviously not
possible under accepted ethical stan-
dards. Also, previous experience (e.g.,
somatic cell nuclear transfer), along
with knowledge about species differ-
ences, showed that findings in one spe-
cific species do not automatically
translate to the human case. Thus,
the developmental competence of a
Box 1. Definition of Terms
d Conceptus: the products of conception at all stages of development from zygote to birth. These include the em-
bryo proper, the fetus, the placenta, and all extraembryonic membranes. The term ‘‘embryo proper’’ refers to
those parts of the conceptus that will form the new body and excludes the extraembryonic tissues. Often, the
terms ‘‘embryo’’ and ‘‘conceptus’’ are used interchangeably.
d Pre-implantation stages of development: the first few days of development, from fertilization to implantation,
during which the conceptus travels down the oviduct toward the uterus. It encompasses the 7–9 days after fertil-
ization in humans.
d Implantation: the process of attachment and invasion of the conceptus to the uterine tissues that occurs around
day 7–9 after fertilization in humans. Implantation establishes the fetal-maternal interface leading to later
placental development. Implantation is mediated by the polar (embryonic side near the epiblast) and mural tro-
phectoderm cells (abembryonic side opposite the epiblast) of the blastocyst.
d Post-implantation stages of development: the stages of development after the conceptus is embedded in the uter-
ine tissues.
d Gastrulation: the process by which the three germ layers of the embryonic compartment of the conceptus are
formed. Gastrulation begins around day 14 in humans.
d Primitive streak: the embryonic structure that establishes bilateral symmetry (alignment of equivalent structures
on both sides of the anterior-posterior axis), the site of gastrulation, and the formation of the germ layers. In hu-
mans, the primitive streak appears after 14 days.
d Embryonic and fetal stages: the embryonic stage begins with the division of the zygote and encompasses the
development of the body plan and formation of the organs. This is followed by the fetal stage, during which
growth and maturation of tissues and organs occurs. In humans, the fetal stage begins during the 9th week after
fertilization and continues to birth.
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model of one species (e.g., the mouse)
is not automatically informative
regarding what could occur in the hu-
man species. In addition to uncer-
tainty regarding how to define organ-
ismic potential in embryo models, it
is also difficult to know how to apply
the 14-day rule to such systems. Stem
cells derived from human blastocysts
or obtained via reprograming do not
have a defined developmental chro-
nology per se (days since fertilization)
because cultures are not precisely con-
strained in vitro and comprise a spec-
trum of concomitant developmental
states. For example, human pluripo-
tent stem cells grown in 3D microflui-
dic devices can form structures resem-
bling the early primitive streak stage
within 48 h of culture. Also, defining
the appearance of specific anatomical
structures as a landmark, such as the
appearance of a primitive streak, can
be prone to interpretation and can be
ascertained only after the culture is
terminated. Finally, both embryos
and in vitro models show variability in
developmental chronology and may
be more advanced or delayed relative
to the average timeline. Altogether,
this uncertainty in the developmental
timing creates difficulties for the appli-
cation of ethical limits, such as the 14-
day rule, to embryo models.
Currently, there is little in theway of
specific guidelines to provide for
proper ethical oversight of this
research, despite the substantial scien-
tific and medical insights to be gained
(Rivron et al., 2018a). It is thus critical
that any discussions on the future of
this research be carried out openly
and on a scientifically informed basis.
To this end, we wish to clarify some
ethical issues relative to different em-
bryo models and put forward some
suggestions regarding guidelines for
the conduct of this research.
General Ethical Considerations
Regarding Embryo Models
1. Constructs that do not attempt
to model the integrated devel-
opment of the entire conceptus
are not equivalent to embryos.
This includes research that ex-
amines single embryonic or
extraembryonic cell lineages
(e.g., epiblast, trophoblast, or
Figure 1. The Different Embryo Models
Models of the embryo have been formed using mouse (left) and human stem cells (right) to
mimic the development of (parts of) the embryo proper (orange) and the extraembryonic
tissues (blue) of the conceptus (gray). Mouse models include blastoids (left, top) that
resemble the pre-implantation 3.5-day-old conceptus, contain analogues of the three
lineages forming the embryo proper, placenta, and yolk sac, and recapitulate aspects of the
implantation into the uterus; ETX embryo models (left, middle) that resemble inner regions
of the early post-implantation 6.5-day-old conceptus, contain analogues of the three
lineages forming the embryo, placenta, and visceral endoderm, mimic an anteroposterior
patterning, and form gastrulating-like cells; and gastruloids (left, bottom) that resemble
the medial and posterior parts of the 8.5-day-old embryo proper form features of the three
orthogonal axes that serve as a reference for the organization of the derivatives of the three
germ layers and an appropriate distribution of the primordia-like cells. Work with human
stem cells is less advanced but is on a similar trajectory. Currently, epiblast-amniotic
models (right, top) recapitulate features of the formation of the amniotic cavity, epiblast-
amniotic ectoderm axis, and gastrulation, while human stem cells grown on 2D micro-
patterns (right, bottom) model aspects of post-implantation patterning. Days 7–9 and day
14 of human development (marked in red) are important biological milestones that
delineate the emergence of specific properties, such as the capacity to implant in the
uterus and the formation of the primitive streak (gastrulation), respectively.
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extraembryonic endoderm) or
combinations of embryonic
and extraembryonic lineages
that are not likely to support
the integrated development of
an intact embryo (e.g., gastru-
loid, epiblast-amniotic sac struc-
tures). In these cases, we can
safely infer from experimental
studies in mice that such
constructs are not able to
develop independently into
embryos or fetuses absent
further complementation with
all extra-embryonic tissues.
Thus, gastruloids, epiblast-am-
niotic sac constructs, andmicro-
patterned cultures can provide
useful models without equiva-
lent ethical concerns.
2. Experimental constructs that
attempt to model the integrated
development of the entire
conceptus need to be carefully
assessed. Without extraembry-
onic tissues, the in vivo develop-
ment of the human conceptus
cannot proceed normally.
Because the trophectoderm of
the blastocyst enables the pro-
cess of in utero implantation,
embryo models that combine
cells mimicking the epiblast
and extraembryonic endoderm
and covered by trophectoderm-
like cells (e.g., blastoids) do raise
the possibility of producing a
construct with further potential
if transferred to the human
uterus. Current research in
mice suggests that the extended
developmental potential of such
models is far from certain at this
point.
3. Regulation of research on hu-
man embryo models that do
attempt to model the integrated
development of the entire
conceptus should be informed
by the current approach to regu-
lation of embryo research. De-
pending on the jurisdiction,
research is currently permitted,
under appropriate oversight, on
Box 2. Examples of Jurisdictions in which the Definition of a Human Embryo Might Capture Embryo
Models Derived from Stem Cells
Country Legal Definition of a Human Embryo Citation
Australia ‘‘A discrete entity that has arisen from either: (a) the first
mitotic division when fertilisation of a human oocyte by a
human sperm is complete; or (b) any other process that
initiates organised development of a biological entity with a
human nuclear genome or altered human nuclear genome
that has the potential to develop up to, or beyond, the stage
at which the primitive streak appears; and has not yet
reached 8 weeks of development since the first mitotic
division.’’
Prohibition of Human Cloning for Reproduction and the
Regulation of Human Embryo Research Amendment Act
2006, no. 172, 2006, http://www.comlaw.gov.au/Details/
C2006A00172.
Japan Article 2 (1)
‘‘(i) Embryo—A cell (except for a Germ Cell) or a cell group
which has the potential to grow into an individual through
the process of development in utero of a human or an animal
and remains at a stage prior to placental formation.’’
Act on Regulation of Human Cloning Techniques (Act no. 146
of 2000), http://www.cas.go.jp/jp/seisaku/hourei/data/
htc.pdf.
United States SEC. 509. ‘‘(a) None of the funds made available in this Act
may be used for—
(1) the creation of a human embryo or embryos for research
purposes; or
(2) research in which a human embryo or embryos are
destroyed, discarded, or knowingly subjected to risk of injury
or death greater than that allowed for research on fetuses in
utero under 45 CFR 46.204(b) and section 498(b) of the
Public Health Service Act (42 U.S.C. 289g(b)).
(b) For purposes of this section, the term ‘human embryo or
embryos’ includes any organism, not protected as a human
subject under 45 CFR 46 as of the date of the enactment of
this Act, that is derived by fertilization, parthenogenesis,
cloning, or any other means from one or more human
gametes or human diploid cells.’’
Dickey-Wicker Amendment, 2009, https://www.congress.
gov/bill/111th-congress/house-bill/1105/text/enr.
[This amendment prohibits the NIH from funding human
embryo research as defined here.]
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established lines of human stem
cells, on parts of embryos, and
on pre-implantation embryos
developed up to 14 days. Appro-
priate mechanisms for review of
such research exist inmost juris-
dictions, e.g., Embryo Research
Oversight (EMRO) in the United
States, Human Fertilization and
Embryo Authority in the United
Kingdom, Stem Cell Oversight
Committee in Canada, and Em-
bryo Research Licensing Com-
mittee in Australia.
4. Support of this research through
peer-reviewed funding by
public agencies and charitable
foundations is critical to ensure
proper scientific and ethical
oversight.
5. Regulation should take into ac-
count the intent of the research.
Human embryo models should
not be created for direct use in
assisted reproduction aimed
at producing a pregnancy but
could be used as in vitro
models to develop improve-
ments to the management of
human reproduction.
6. Oversight should consider
both the potential biomedical
benefits of the work and its sci-
entific quality. Oversight and
approval should take into ac-
count the ethical and practical
benefits of replacing human
embryo material with broadly
available stem cell lines. How-
ever, the scientific rationale
and quality of the proposed
research need to be carefully
evaluated.
Recommendations for Oversight
of Research on Specific Model
Systems
1. Culture systems that model
pre-implantation development
and post-implantation develop-
ment up to gastrulation by
incorporating human embry-
onic and extraembryonic line-
ages, including the trophoblast
and extraembryonic endoderm,
with the intent to represent
the integrated development of
the entire conceptus up to the
appearance of the primitive
streak (for example, blastoids or
ETX models) are permissible
only following oversight by
EMRO in the United States or
equivalent ethics review else-
where (or more extensive
review where local regulations
require it).
2. Culture systems that do not
model the integration of all em-
bryonic and extraembryonic
lineages or models that clearly
lack the potential to form a full
organism are exempt from
mandatory review but are notifi-
able to the EMRO or equivalent
and subject to review should
the cognizant body deem it
necessary.
3. Culture systems that model hu-
man gastrulation and subse-
quent stages (beyond the
appearance of the primitive
streak) are exempt from manda-
tory review if they do not
encompass all major lineages of
the conceptus (embryonic and
extraembryonic) in an intact
construct and are aimed at
studying a discrete and defined
period of development or
discrete set of anatomic struc-
tures, rather than modeling the
continuous development of an
intact embryo or fetus (for
example, models of the neural
tube or micropatterned stem
cell cultures forming three
germ layers, or gastruloids).
Such research would be notifi-
able to the EMRO or equivalent
and subject to review should
Box 3. Sections of Current International Society for Stem Cell Research Guidelines Relevant to Embryo
Models
FORMS OF RESEARCH THAT ARE PERMISSIBLE ONLY AFTER REVIEW BY AN EMRO PROCESS
Research involving the in vitro culture of embryos or experimental generation of embryo-like structures that might
manifest humanorganismal potential, to ensureminimal periods of in vitro culture, as justified by compelling scientific
rationale.
PROHIBITED RESEARCH ACTIVITIES
a. In vitro culture of any intact human pre-implantation embryo or organized embryo-like cellular structure with
human organismal potential, regardless of derivation method, beyond 14 days or formation of the primitive
streak, whichever occurs first.
b. Experiments whereby human embryos or organized cellular structures that might manifest human organismal
potential are gestated ex utero or in any non-human animal uterus.
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the cognizant body deem it
necessary.
4. A human embryo model that
was disassembled at the time of
appearance of the primitive
streak into component parts for
further culture or study in vitro
would no longer be subject to
the strict considerations sug-
gested in (1) and may be deter-
mined to be exempt from
further committee review.
5. The in vitro combination of hu-
man embryo models with ani-
mal or human cells or tissues or
embryos should be subject to
the same limitations in (1) and
(2) above and mandatory re-
view. This category would
include in vitro human/animal
embryo model chimeras, em-
bryomodel/human embryo chi-
meras, or any of these constructs
implanted in vitro into ex-
planted uterine tissues or uter-
ine organoids.
6. No human embryo model in
any of the above categories shall
be transferred in vivo into the
uterus of an animal or human.
Next Steps
Research in this area is evolving
rapidly and the support of this
research by public agencies and chari-
table foundations is critical to ensure
proper scientific and ethical oversight.
An open, broadly based consultative
process needs to occur so that a regula-
tory framework can be carefully devel-
oped. Any proposed regulations
should be clear and take into account
the potential benefits of this research
and the unique power of these
models. Publicly accountable regula-
tory oversight is preferable to proscrip-
tive legislation that could have unin-
tended negative consequences in the
future. The ISSCR is in a strong posi-
tion tomake authoritative recommen-
dations for the conduct of this
research, as it has done in the past
for other ethically challenging issues
within its remit. The current ISSCR
guidelines (ISSCR 2016 Guidelines
for Stem Cell Research and Clinical
Translation http://www.isscr.org/
membership/policy/2016-guidelines/
guidelines-for-stem-cell-research-and-
clinical-translation, Box 3) provide
some baseline recommendations rele-
vant to this research but need to be
clarified and expanded in the light of
the rapid progress in this field. We
put forward our recommendations as
a starting point for discussions within
the Society and the community at
large.
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